We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+18.16%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$103M
AUM Growth
-$16.6M
Cap. Flow
+$18.5M
Cap. Flow %
17.87%
Top 10 Hldgs %
86.72%
Holding
35
New
11
Increased
6
Reduced
9
Closed
8

Top Buys

Rank Stock Value
1
WGS icon
GeneDx Holdings
WGS
+$9.23M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$5.89M
3
DMTK
DermTech, Inc. Common Stock
DMTK
+$2.98M
4
OMGA
Omega Therapeutics, Inc. Common Stock
OMGA
+$2.32M
5
SWTX
SpringWorks Therapeutics
SWTX
+$1.27M

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$26.4M
2
MRNA icon
Moderna
MRNA
+$5.55M
3
AGEN
Agenus
AGEN
+$2.04M
4
PACB icon
Pacific Biosciences
PACB
+$1.39M
5
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$1.37M

Sector Composition

Rank Sector Weight
1 Healthcare 96.82%
2 Energy 0.48%
3 Industrials 0.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PACB icon
1
Pacific Biosciences
PACB
$432M
$23.3M 22.59%
2,015,495
-139,312
-6% -$1.39M
QDEL icon
2
QuidelOrtho
QDEL
$1.14B
$17.5M 16.9%
196,008
-303,255
-61% -$26.4M
WGS icon
3
GeneDx Holdings
WGS
$1.84B
$9.24M 8.95%
767,517
+692,062
+917% +$9.23M
BHVN icon
4
Biohaven
BHVN
$2.07B
$8.68M 8.4%
635,476
+28,700
+5% +$457K
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$7.49M 7.25%
201,400
+130,947
+186% +$5.89M
AGEN
6
Agenus
AGEN
$275M
$6M 5.8%
201,003
-48,187
-19% -$2.04M
FORA
7
DELISTED
Forian
FORA
$5.2M 5.03%
1,364,329
+13,072
+1% +$45.5K
BCRX icon
8
BioCryst Pharmaceuticals
BCRX
$2.48B
$4.63M 4.48%
555,522
-29,672
-5% -$286K
OPK icon
9
Opko Health
OPK
$1.25B
$4.15M 4.02%
2,843,165
-387,123
-12% -$498K
ARDX icon
10
Ardelyx
ARDX
$1.25B
$3.4M 3.29%
709,700
-59,530
-8% -$201K
DMTK
11
DELISTED
DermTech, Inc. Common Stock
DMTK
$3.3M 3.2%
897,449
+706,680
+370% +$2.98M
IMMP
12
Immutep
IMMP
$57M
$2.27M 2.2%
1,350,802
-91,523
-6% -$168K
OMGA
13
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$2.01M 1.95%
+333,836
New +$2.32M
SWTX
14
DELISTED
SpringWorks Therapeutics
SWTX
$1.12M 1.08%
+43,500
New +$1.27M
AXDX
15
DELISTED
Accelerate Diagnostics
AXDX
$1.06M 1.02%
151,065
-11,743
-7% -$70.6K
TQQQ icon
16
ProShares UltraPro QQQ
TQQQ
$30.5B
$687K 0.67%
280,000
-120,000
-30% -$1.37M
BIIB icon
17
Biogen
BIIB
$30.4B
$671K 0.65%
2,412
– –
VTNR
18
DELISTED
Vertex Energy, Inc
VTNR
$494K 0.48%
+50,000
New +$397K
QDEL icon
19
CALL
QuidelOrtho
QDEL
$1.14B
$477K 0.46%
+49,400
New +$4.3M
CNC icon
20
CALL
Centene
CNC
$31.6B
$370K 0.36%
+175,000
New +$12.4M
OPK icon
21
CALL
Opko Health
OPK
$1.25B
$313K 0.3%
+614,300
New +$791K
VTNR
22
CALL
DELISTED
Vertex Energy, Inc
VTNR
$245K 0.24%
100,400
+400
+0.4% +$3.17K
VLD
23
DELISTED
Velo3D, Inc.
VLD
$200K 0.19%
+2,522
New +$226K
MCK icon
24
PUT
McKesson
MCK
$104B
$184K 0.18%
+20,000
New +$7.22M
CAH icon
25
PUT
Cardinal Health
CAH
$54.5B
$112K 0.11%
+130,000
New +$9.81M
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q1 2023 Portfolio in Review

As of Q1 2023, Oracle Investment Management held 35 positions worth $103M, down 14% from $120M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Oracle Investment Management deployed $18.5M of net new capital in Q1 2023, opening 11 new positions and adding to 6 existing holdings. Its largest new stake was Omega Therapeutics, Inc. Common Stock: 333,836 shares worth $2.01M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 93% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was QuidelOrtho, an estimated $26.4M trimmed.

  • Oracle Investment Management's largest Q1 2023 buy was Omega Therapeutics, Inc. Common Stock: 333,836 shares worth $2.01M.
  • Oracle Investment Management added most to GeneDx Holdings in Q1 2023, an estimated $9.23M increase.
  • Oracle Investment Management's biggest Q1 2023 reduction was QuidelOrtho, cutting an estimated $26.4M.
  • Oracle Investment Management fully exited Moderna in Q1 2023, selling an estimated $5.55M.
  • Oracle Investment Management's ten largest holdings make up 87% of its $103M portfolio in Q1 2023.
  • Oracle Investment Management opened 11 new positions and closed 8 in Q1 2023.
  • Oracle Investment Management's portfolio value fell 14% quarter-over-quarter to $103M.

Based on Oracle Investment Management's 13F filing for Q1 2023, filed 15 May 2023.